Combinations for cancer prevention
- 1 September 2000
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 6 (9), 974-975
- https://doi.org/10.1038/79664
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Combinatorial chemoprevention of intestinal neoplasiaNature Medicine, 2000
- Trastuzumab in the Treatment of Metastatic Breast CancerCirculation, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Host cyclooxygenase-2 modulates carcinoma growthJCI Insight, 2000
- Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid ArthritisJama-Journal Of The American Medical Association, 1999
- PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory DrugsCell, 1999
- A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritisGastroenterology, 1999
- Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.Journal of Clinical Oncology, 1998
- Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer CellsCell, 1998